Use of Teratogenic Medicines in Women of Reproductive Age

Authors

Krys E. Foster, MD, MPH, Thomas Jefferson UniversityFollow

Document Type

Presentation

Presentation Date

5-25-2017

Abstract

Outline:

Teratogenic medications are commonly prescribed to women of reproductive age.

Despite knowledge of potential teratogenic effects, effective communication regarding the risks and benefits of medication use in the context of the patient’s fertility goals remains inadequate.

This lecture will discuss recommendations to facilitate thoughtful prescribing in this population

Presentation: 38:17

Recommended Citation

Foster, MD, MPH, Krys E., "Use of Teratogenic Medicines in Women of Reproductive Age" (2017). Department of Family & Community Medicine Presentations and Grand Rounds. Paper 194.
https://jdc.jefferson.edu/fmlectures/194